Skip to content
★ Sign in to follow
Voronoi, Inc. logo

Voronoi, Inc. Stock: price and insider trades · South Korea

보로노이

KR·Mcap ₩1.9THealth Care

No insider purchase over the last 90 days. The latest, by 이상진, was filed 08 Jun 2026.

Insider Decl.
66
Thresholds
n/a
Buy Volume
€16M
21 ops. · all time
Sell Volume
€12M
13 ops. · all time

Who traded when

BuySale
김현태4 sales
김대권3 sales
우상진3 sales
김성환1 buy1 sale
이상진1 buy1 sale
Fundamental score
Ranked 18,948 of 26,897 companies
37.8
score / 100
Value
25
Quality
51
FCF yld-4.2%
Earn yld-2.4%
EV/EBITDA·
ROE-119%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩106,100
Analyst consensus
2 analysts
1.50/5
₩230,000Target ₩340,000(+220%)₩450,000
Income statement
Revenue₩7.5B
Gross profit₩7.5B100% margin
EBITDA-₩46.2B-615% margin
Net income-₩42.7B-568.5% margin
Valuation
PER (forward)-29.9x
Beta1.56
Balance sheet & cash
Market cap₩1.9T
Total debt₩39.8B
Free Cash Flow-₩73.8B
Debt / Equity49%
Profitability & ownership
ROE-119.4%
ROA-54.7%
% insiders39.1%
% institutions8.6%
Last declaration on 3 July 2026
Declarations68 total
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ▼
    연구부문 대표이사Executives(filed)
    €411kest.0DART
    4,050 sharesShareKRXDART:20260703000590
  • ▼
    COOExecutives(filed)
    €203kest.0DART
    2,000 sharesShareKRXDART:20260703000623
  • ▼
    대량보유자Executives(filed)
    €2.2Mest.0DART
    21,305 sharesKRXDART:20260703000489
  • ▼
    이사Executives(filed)
    €305kest.0DART
    3,000 sharesShareKRXDART:20260703000639
  • ▼
    이사Executives(filed)
    €406kest.0DART
    4,000 sharesShareKRXDART:20260703000636
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    이사Executives(filed)
    €318kest.0DART
    3,000 sharesShareKRXDART:20260608000302
    Canonical exit: 6 Sept 2026 (T+90)
  • ▲
    이사Executives(filed)
    €424kest.0DART
    4,000 sharesShareKRXDART:20260608000280
    Canonical exit: 6 Sept 2026 (T+90)
  • ●
    Executives
    0DART
    0KRXDART:20260527000347
  • ▼
    Executives
    €1.4Mest.0DART
    8,000 sharesKRXDART:20260415000506
  • ▼
    연구부문 대표이사Executives
    €333kest.0DART
    2,000 sharesShareKRXDART:20260415000485
  • ▼
    COOExecutives
    €333kest.0DART
    2,000 sharesShareKRXDART:20260415000492
  • ▼
    Executives
    €160kest.0DART
    1,000 sharesKRXDART:20260403002925
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    0DART
    0KRXDART:20260305000811
  • ●
    Executives
    0DART
    0KRXDART:20260224001214
  • ●
    Executives
    0DART
    0KRXDART:20251230000236
  • ●
    Executives
    0DART
    0KRXDART:20251218000451
  • ●
    Executives
    0DART
    0KRXDART:20251215000317
  • ●
    Executives
    Executives
    0DART
  • ▼
    대량보유자Executives
    €2.9Mest.0DART
    23,998 sharesKRXDART:20251107000575
  • ▼
    COOExecutives(filed)
    €474kest.0DART
    3,900 sharesShareKRXDART:20251107000572

25 of 68 declarations

About Voronoi, Inc.

Voronoi, Inc. (보로노이) entered this record later than the others: the first filing was published on June 28, 2022 and the latest on July 3, 2026, 66 filings from 6 filers. 김현태, filed as 대량보유자, made 34, including 17 purchases and 5 sales. 김대권 (연구부문 대표이사) has 22, with 1 purchase and 3 sales, 우상진 (COO) has 4, with 1 purchase and 3 sales, and 이상진 and 김성환 (이사) have 2 each, 1 purchase and 1 sale.

Open-market trades are 21 purchases and 13 sales, 62% purchases, but none carries an amount, so no euro total can be given. 32 filings are of another kind. On June 8, 2026, 2 filers bought on the same day.

Read moreShow less

Volume reached 28 filings in 2023, then 5 in 2024, 10 in 2025 and 17 in 2026. The most recent 12 months show 24 filings, 2 purchases and 12 sales, with a median delay of 2 days from trade to publication. This health care company is valued at KRW 2.5 trillion, and insiders hold 39.1% of the capital.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations